{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:55:57Z","timestamp":1776329757845,"version":"3.50.1"},"reference-count":21,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.6002\/ect.mesot2021.p54","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T03:11:39Z","timestamp":1649301099000},"page":"125-128","source":"Crossref","is-referenced-by-count":1,"title":["Cytomegalovirus Viremia in Solid-Organ Transplant Patients in the First Year After Transplantation"],"prefix":"10.6002","volume":"20","author":[{"given":"\u00c7i\u011fdem","family":"Erol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayd\u0131ncan","family":"Akdur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Haberal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13512. doi:10.1111\/ctr.13512","DOI":"10.1111\/ctr.13512"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Lachmann R, Loenenbach A, Waterboer T, et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS One. 2018;13(7):e0200267. doi:10.1371\/journal.pone.0200267","DOI":"10.1371\/journal.pone.0200267"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034. doi:10.1002\/rmv.2034","DOI":"10.1002\/rmv.2034"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Hoehl S, Berger A, Ciesek S, Rabenau HF. Thirty years of CMV seroprevalence-a longitudinal analysis in a German university hospital. Eur J Clin Microbiol Infect Dis. 2020;39(6):1095-1102. doi:10.1007\/s10096-020-03814-x","DOI":"10.1007\/s10096-020-03814-x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202-213. doi:10.1002\/rmv.655","DOI":"10.1002\/rmv.655"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Uysal A, Taner CE, Cuce M, et al. Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir\/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet. 2012;286(3):605-608. doi:10.1007\/s00404-012-2353-z","DOI":"10.1007\/s00404-012-2353-z"},{"key":"ref6","unstructured":"7. Uyar Y, Balci A, Akcali A, Cabar C. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol. 2008;31(4):451-455."},{"key":"ref7","unstructured":"8. Ataman S, Colak D, Gunseren F, et al. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey]. Mikrobiyol Bul. 2007;41(4):545-555."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Sagedal S, Hartmann A, Nordal KP, et al. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 2004;66(1):329-337. doi:10.1111\/j.1523-1755.2004.00735.x","DOI":"10.1111\/j.1523-1755.2004.00735.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Ricart MJ, Malaise J, Moreno A, Crespo M, Fernandez-Cruz L; Euro SPKSG. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant. 2005;20 Suppl 2:ii25-ii32, ii62. doi:10.1093\/ndt\/gfh1079","DOI":"10.1093\/ndt\/gfh1079"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Borchers AT, Perez R, Kaysen G, Ansari AA, Gershwin ME. Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms. Transpl Immunol. 1999;7(2):75-82. doi:10.1016\/s0966-3274(99)80023-9","DOI":"10.1016\/S0966-3274(99)80023-9"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol. 2007;19(5):577-582. doi:10.1016\/j.coi.2007.07.012","DOI":"10.1016\/j.coi.2007.07.012"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Azevedo LS, Pierrotti LC, Abdala E, et al. Cytomegalovirus infection in transplant recipients. Clinics (Sao Paulo). 2015;70(7):515-523. doi:10.6061\/clinics\/2015(07)09","DOI":"10.6061\/clinics\/2015(07)09"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013;45(3):260-271. doi:10.3947\/ic.2013.45.3.260","DOI":"10.3947\/ic.2013.45.3.260"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Paya C, Humar A, Dominguez E, et al; Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4(4):611-20. doi:10.1111\/j.1600-6143.2004.00382.x","DOI":"10.1111\/j.1600-6143.2004.00382.x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Dioverti MV, Razonable RR. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients. Curr Opin Infect Dis. 2015;28(4):317-22. doi:10.1097\/QCO.0000000000000173","DOI":"10.1097\/QCO.0000000000000173"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013;26(4):703-727. doi:10.1128\/CMR.00015-13","DOI":"10.1128\/CMR.00015-13"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Natori Y, Alghamdi A, Tazari M, et al; CMV Consensus Forum. Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis. Clin Infect Dis. 2018;66(4):617-631. doi:10.1093\/cid\/cix793. PMID: 29020339.","DOI":"10.1093\/cid\/cix793"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Cervera C, Gurgu\u00ed M, Lumbreras C. Factores de riesgo de la enfermedad por citomegalovirus en el receptor de un trasplante de \u00f3rgano s\u00f3lido [Risk factors for cytomegalovirus in solid organ transplant recipients]. Enferm Infecc Microbiol Clin. 2011;29 Suppl 6:11-17. doi:10.1016\/S0213-005X(11)70051-9","DOI":"10.1016\/S0213-005X(11)70051-9"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Linares L, Sanclemente G, Cervera C, et al. Influence of cytomegalovirus disease in outcome of solid organ transplant patients. Transplant Proc. 2011;43(6):2145-2148. doi:10.1016\/j.transproceed.2011.05.007","DOI":"10.1016\/j.transproceed.2011.05.007"},{"key":"ref20","unstructured":""}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T04:25:43Z","timestamp":1649305543000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/supplement\/2022\/20\/3\/1\/125\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2021.p54","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}